ABIZYME

Welcome to the Brand page for “ABIZYME”, which is offered here for Human pharmaceutical preparations for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases; human pharmaceutical preparations, hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “ABIZYME” is believed to be currently owned by “Johnson & Johnson”.